Cargando…
Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior. Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative. Recently, Memoquin (MQ), a quinone-bearing polyamine compound, h...
Autores principales: | Capurro, Valeria, Busquet, Perrine, Lopes, Joao Pedro, Bertorelli, Rosalia, Tarozzo, Glauco, Bolognesi, Maria Laura, Piomelli, Daniele, Reggiani, Angelo, Cavalli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575497/ https://www.ncbi.nlm.nih.gov/pubmed/23441223 http://dx.doi.org/10.1371/journal.pone.0056870 |
Ejemplares similares
-
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
por: Lopes, João P, et al.
Publicado: (2013) -
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
por: Fu, Jin, et al.
Publicado: (2011) -
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane
Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing
Acid Amidase (NAAA) Inhibitors for Oral Administration
por: Di Fruscia, Paolo, et al.
Publicado: (2021) -
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
por: Reggiani, Angelo M., et al.
Publicado: (2016) -
Lymphopenia predicts 30-day morbidity and mortality following spinal metastasis surgery
por: Anzuatégui, Pedro Reggiani, et al.
Publicado: (2021)